Diagnostics
A practical, tiered testing framework

Diagnostics support baseline assessment, risk profiling, and safer HRT monitoring — compatible with decentralised at‑home testing and local phlebotomy hubs.

Onboarding

Baseline panel (example)

This is an example panel and should be adapted to clinical protocols and patient context.

  • Thyroid profile (TSH, FT4 ± FT3)
  • Full blood count, ferritin
  • Vitamin D
  • Liver & renal function
  • Hormone markers as clinically indicated
Risk profiling

Cardio‑metabolic panel

  • Lipids
  • HbA1c
  • hs‑CRP (where appropriate)
  • Insulin (optional)

The platform can prompt screening when symptom patterns suggest elevated risk (e.g., weight change + fatigue + sleep disruption) — while ensuring clinician review before action.

Optimisation

HRT monitoring

  • Oestradiol (and progesterone as needed)
  • SHBG
  • Testosterone (total + free where appropriate)
  • LFTs

Monitoring intervals depend on tier and clinical context. The platform can automate reminders and provide result trends, reducing missed follow‑ups.

Tier 3–4

Advanced add‑ons

  • ApoB, Lipoprotein(a)
  • Thyroid antibodies (anti‑TPO, anti‑TG)
  • Cortisol (morning)
  • Bone markers and DEXA referral when indicated
Advanced tests such as DUTCH can be positioned as optional lifestyle insight add‑ons — not required for standard menopause diagnosis or routine HRT decisions.
Testing frequency

Example by subscription tier

TierMonitoring approachTypical testing cadence (example)
Tier 1Education + trackingNo routine testing included; prompts to seek care when needed.
Tier 2Clinician accessBaseline + annual monitoring; additional tests as clinically indicated.
Tier 3Bundled diagnosticsBaseline + 6–12 month monitoring + HRT panels as needed.
Tier 4Advanced supportBaseline + 6‑month monitoring + advanced markers and higher‑touch reviews.
All testing should follow clinician judgement and protocol alignment.